The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Deranged Calcium Signaling and Neurodegeneration in Spinocerebellar Ataxia Type 2
Open accessAbstract
Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominantly inherited, neurodegenerative disease caused by an expansion of polyglutamine tracts in the cytosolic protein ataxin-2 (Atx2). Cerebellar Purkinje cells (PCs) are predominantly affected in SCA2. The cause of PC degeneration in SCA2 is unknown. Here we demonstrate that mutant Atx2–58Q, but not wild-type (WT) Atx2–22Q, specifically associates with the cytosolic C-terminal region of type 1 inositol 1,4,5-trisphosphate receptor (InsP 3 R1), an intracellular calcium (Ca 2+) release channel. Association with Atx2–58Q increased the sensitivity of InsP 3 R1 to activation by InsP 3 in planar lipid bilayer reconstitution experiments. To validate physiological significance of these findings, we performed a series of experiments with an SCA2–58Q transgenic mouse model that expresses human full-length Atx2–58Q protein under the control of a PC-specific promoter. In Ca 2+imaging experiments, we demonstrated that stimulation with 3,5-dihydroxyphenylglycine (DHPG) resulted in higher Ca 2+responses in 58Q PC cultures than in WT PC cultures. DHPG-induced Ca 2+responses in 58Q PC cultures were blocked by the addition of ryanodine, an inhibitor of the ryanodine receptor (RyanR). We further demonstrated that application of glutamate induced more pronounced cell death in 58Q PC cultures than in WT PC cultures. Glutamate-induced cell death of 58Q PC cultures was attenuated by dantrolene, a clinically relevant RyanR inhibitor and Ca 2+stabilizer. In whole animal experiments, we demonstrated that long-term feeding of SCA1–58Q mice with dantrolene alleviated age-dependent motor deficits (quantified in beam-walk and rotarod assays) and reduced PC loss observed in untreated SCA2–58Q mice by 12 months of age (quantified by stereology). Results of our studies indicate that disturbed neuronal Ca 2+signaling may play an important role in SCA2 pathology and also suggest that the RyanR constitutes a potential therapeutic target for treatment of SCA2 patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
West, M. J., Slomianka, L., & Gundersen, H. J. G. (1991) · The Anatomical Record · doi:10.1002/ar.1092310411 · Cited by 2,994
Bezprozvanny, L., Watras, J., & Ehrlich, B. E. (1991) · Nature · doi:10.1038/351751a0 · Cited by 1,712
Zhuchenko, O., Bailey, J., Bonnen, P., Ashizawa, T., Stockton, D. W., Amos, C., Dobyns, W. B., Subramony, S. H., Zoghbi, H. Y., & Lee, C. C. (1997) · Nature Genetics · doi:10.1038/ng0197-62 · Cited by 1,583
Glutamine Repeats and Neurodegeneration
Zoghbi, H. Y., & Orr, H. T. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.217 · Cited by 1,309
Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2
Pulst, S.-M., Nechiporuk, A., Nechiporuk, T., Gispert, S., Chen, X.-N., Lopes-Cendes, I., Pearlman, S., Starkman, S., Orozco-Diaz, G., Lunkes, A., et al. (1996) · Nature Genetics · doi:10.1038/ng1196-269 · Cited by 1,113
Self-citationAutosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis
Schöls, L., Bauer, P., Schmidt, T., Schulte, T., & Riess, O. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00737-9 · Cited by 1,058
Primary structure and functional expression of the inositol 1,4,5-trisphosphate-binding protein P400
Furuichi, T., Yoshikawa, S., Miyawaki, A., Wada, K., Maeda, N., & Mikoshiba, K. (1989) · Nature · doi:10.1038/342032a0 · Cited by 1,049
Ataxin-1 Nuclear Localization and Aggregation
Klement, I. A., Skinner, P. J., Kaytor, M. D., Yi, H., Hersch, S. M., Clark, H. B., Zoghbi, H. Y., & Orr, H. T. (1998) · Cell · doi:10.1016/s0092-8674(00)81781-x · Cited by 956
Imbert, G., Saudou, F., Yvert, G., Devys, D., Trottier, Y., Garnier, J.-M., Weber, C., Mandel, J.-L., Cancel, G., Abbas, N., et al. (1996) · Nature Genetics · doi:10.1038/ng1196-285 · Cited by 849
Sanpei, K., Takano, H., Igarashi, S., Sato, T., Oyake, M., Sasaki, H., Wakisaka, A., Tashiro, K., Ishida, Y., Ikeuchi, T., et al. (1996) · Nature Genetics · doi:10.1038/ng1196-277 · Cited by 763
Cited by
The Inositol Trisphosphate/Calcium Signaling Pathway in Health and Disease
Berridge, M. J. (2016) · Physiological Reviews · doi:10.1152/physrev.00006.2016 · Cited by 753
Neuronal calcium signaling: function and dysfunction
Brini, M., Calì, T., Ottolini, D., & Carafoli, E. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1550-7 · Cited by 748
Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond
Durr, A. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70183-6 · Cited by 656
Calcium signaling and neurodegenerative diseases
Bezprozvanny, I. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.01.001 · Cited by 469
Self-citationRüb, U., Schöls, L., Paulson, H., Auburger, G., Kermer, P., Jen, J. C., Seidel, K., Korf, H.-W., & Deller, T. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.01.001 · Cited by 346
Metadata
- Authors
- Liu, J., Tang, T.-S., Tu, H., Nelson, O., Herndon, E., Huynh, D. P., Pulst, S. M., & Bezprozvanny, I.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2009-07-22
- Volume
- 29
- Issue
- 29
- Pages
- 9148-9162
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2115807468
- Cited by
- 299
- References
- 72
- FWCI
- 9.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Deranged Calcium Signaling and Neurodegeneration in Spinocerebellar Ataxia Type 2. https://app.cochat.ai/papers/10.1523/jneurosci.0660-09.2009
- The paper
- Liu, J., Tang, T.-S., Tu, H., Nelson, O., Herndon, E., Huynh, D. P., Pulst, S. M., & Bezprozvanny, I. (2009). Deranged Calcium Signaling and Neurodegeneration in Spinocerebellar Ataxia Type 2. The Journal of Neuroscience. https://doi.org/10.1523/jneurosci.0660-09.2009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.